시장보고서

상품코드

1509807

풍선 대동맥 판막 성형술 시장 : 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 - 제품 유형별, 지역별 분석

Balloon Aortic Valvuloplasty Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type and Geography

발행일: 2024년 06월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 160 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

풍선 대동맥 판막 성형술 시장 규모는 2023년 1억 2,508만 달러에서 2031년 1억 9,027만 달러에 이르고, 2023-2031년간 연평균 5.4% 성장할 것으로 예측됩니다. 대동맥판막 협착증의 유병률 증가와 최소침습적 시술에 대한 수요 증가는 풍선 대동맥판막 성형술 시장 규모 확대에 기여하는 주목할 만한 요인입니다. 그러나 높은 시술 비용은 풍선 대동맥 판막 성형술 시장의 성장을 저해하는 요인으로 작용하고 있습니다.

TAVR(경피적 대동맥 판막 치환술)은 원래 수술이 불가능하거나 매우 위험한 중증 대동맥판막 협착증 환자만을 대상으로 했습니다. 그러나 밸브 기술의 지속적인 기술 발전과 무작위 임상시험 결과에 따라 젊은 저위험 환자들에게도 사용되기 시작하면서 대동맥판막증 치료의 주류로 자리 잡고 있습니다. 판막 제조 기술의 발전으로 생체 판막은 더욱 보편화되어 더 젊고 저위험 환자에게 적용되고 있습니다. 저침습적 특성으로 인해 조만간 대부분의 판막 치환술이 TAVR을 통해 이루어질 것으로 예상됩니다. 차세대 경 카테터 심장 판막은 시술의 효과, 안전성 및 환자 결과를 크게 개선하여 TAVR을 다양한 환자 위험 그룹에게 매력적인 옵션으로 만들고 있습니다.

이식 시 심장판막의 성능을 예측하는 것은 성공적인 TAVR을 위해 결정적으로 중요합니다. 이식 후 합병증을 최소화하고 적절한 판막 기능을 보장하기 위해서는 이식 전에 선택한 심장 판막을 기계적으로 평가하는 것이 바람직합니다. 심장 판막의 기계적 평가에 공학적 분석을 적용하기 위한 실용적이고 효과적인 솔루션으로 딥러닝(DL) 기반 시스템을 도입하여 TAVR과 관련된 계산 생역학 분석을 발전시키고 단순화하는 것이 고려되고 있습니다. 최근 딥러닝(DL) 기술의 비약적인 발전으로 이미지 분류, 이미지 세분화, 물체 감지 등 다양한 컴퓨터 비전 작업에서 최첨단 성능을 발휘하고 있으며, DL은 진단, 예후 진단, 위험도 분류, 치료/수술 계획 등 다양한 심장 영상 응용을 위해 널리 연구되고 있습니다. TAVR의 수술 후 합병증 및 인공판막 결손을 예측하기 위해 TAVR의 결과를 평가하기 위한 DL 접근법이 수많은 연구에서 연구되고 있습니다.

지속적인 연구 개발로 TAVR의 미래는 획기적인 가능성을 약속하며, 심혈관 치료의 혁신적 치료법으로서의 입지를 더욱 공고히 하고 있습니다. 현재 FDA의 승인을 받은 제품은 에드워즈 사피엔 3 울트라(Edwards SAPIEN 3 Ultra), 메드트로닉 EVOLUT FX, 애보트 네비게이터(Abbott Navitor) 밸브뿐이며, TAVR 임상 경험의 대부분은 에드워즈와 메드트로닉의 밸브 시스템과 관련되어 있지만, 잠재적인 경피적 심장판막의 TAVR의 미래는 적응증 확대, 시술량 급증, 시술 제공 임상 시설 증가 등 밝아 보이지만, 장기적인 내구성은 여전히 중요한 관심사입니다. 현재 사용 가능한 판막 리플렛은 돼지 또는 소의 심막 조직에서 유래합니다. 장기적인 내구성을 향상시키기 위해 독창적 인 전단 재료 및 기타 설계상의 독창성을 통합 한 새로운 밸브 플랫폼이 개발되고 있습니다. 몇 가지 새로운 임상시험은 장기적인 솔루션을 제공하려는 TAVR 시술자에게 중요한 지침을 제공할 것을 약속합니다. SMART(i.e., Small Annuli Randomized to Evolut or SAPIEN) 시험은 가장 일반적으로 사용되는 두 개의 가장 일반적으로 사용되는 두 가지 TAVR 장치인 SAPIEN 3와 Evolut에 대한 업계(메드트로닉) 후원 최초의 무작위 두군간 비교 시험입니다. 이 시험은 북미, 유럽, 중동 및 아프리카의 83개 국제 시설에서 실시되었습니다. 이 시험에는 대동맥륜이 작고(다중 검출기 컴퓨터 단층 촬영 기준 대동맥륜 면적이 430mm2 이하) 증상이 있는 고도의 선천성 대동맥판막 협착증 환자 716명이 등록되었으며, 2024년 4월 미국심장학회(American College of Cardiology)는 SMART 시험 결과, Evolut 판막으로 TAVR을 받은 대동맥 판막륜이 작은 환자는 SAPIEN 3 판막으로 TAVR을 받은 환자와 비교하여 1년 후 임상 결과가 동등하고 판막 성능이 더 우수하다는 것을 증명했다고 발표했습니다. 연구진은 이 결과가 두 판막 유형의 임상 결과에서 유망하다고 밝혔습니다. 연구진은 향후 5년 동안 결과를 계속 추적할 계획입니다. 이처럼 TAVI 시술의 개선에 초점을 맞춘 연구 개발 활동은 풍선 대동맥 판막 성형술 시장에 새로운 트렌드를 가져올 가능성이 높습니다.

제품 유형별 인사이트

제품 유형별로 풍선 대동맥 판막 성형술 시장은 비순응형 풍선과 반순응형 풍선으로 구분됩니다. 비순응형 풍선 부문은 2023년 풍선 대동맥 판막 성형술 시장에서 더 큰 점유율을 차지하고 있으며, 2023년에서 2031년 사이에 시장에서 더 높은 CAGR을 나타낼 것으로 예상됩니다.

이 풍선 대동맥 판막 성형술 시장 보고서는 National Echo Database of Australia와 Institute of Health Economics를 1차 및 2차 정보로 인용하여 작성되었습니다.

북미
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주
- 아시아태평양 기타 국가
중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트(UAE)
- 기타 중동 및 아프리카
중남미
- 브라질
- 아르헨티나
- 기타 중남미

제9장 기업 개요

B Braun SE
TT Medical, Inc.
Balton
Becton Dickinson and Co
Edwards Lifesciences Corp
Balt
Venus MedTech HangZhou Inc
NuMED
Simeks
OSYPKA

제10장 부록

LSH 24.07.17

The balloon aortic valvuloplasty market size is expected to grow from US$ 125.08 million in 2023 to US$ 190.27 million by 2031; it is projected to register a CAGR of 5.4% during 2023-2031. The rising prevalence of aortic valve stenosis and increasing demand for minimally invasive procedures are noteworthy factors contributing to the expansion of the balloon aortic valvuloplasty market size. However, the high cost of procedures hinders the balloon aortic valvuloplasty market growth.

TAVR was originally considered only for patients with severe aortic stenosis who were considered inoperable or at very high risk. However, continuous technological evolution in valve technology and the results of randomized trials have expanded its usage to younger and lower-risk patients, making it a mainstream treatment for aortic valve disease. With developments in valve production technologies, bioprosthetic heart valves are becoming more popular and applicable to younger and lower-risk patients. With its minimally invasive feature, a majority of valve replacements will soon be via TAVR. New-generation transcatheter heart valves have substantially improved procedural efficacy, safety, and patient outcomes, making TAVR an appealing option for different patient risk groups.

Predicting the performance of the heart valve upon implantation is critically important for a successful TAVR. It is desirable to mechanically assess selected heart valves before implantation to ensure proper valve function with minimal complications after implantation. A potential practical and effective solution for applying engineering analysis to the mechanical assessment of heart valves is incorporating deep learning (DL)-based systems to advance and simplify the computational biomechanical analyses relevant to TAVR. In recent years, immense developments in DL techniques have led to state-of-the-art performances in many computer vision tasks, including image classification, image segmentation, and object detection. DL has been extensively investigated for various cardiac imaging applications, including diagnostic, prognostic, risk stratification, and therapeutic/surgical treatment planning. Numerous studies have investigated DL approaches for assessing TAVR outcomes to predict postoperative complications and prosthetic valve defects.

Through continuous research and development, the future of TAVR promises breakthrough possibilities, further strengthening its place as a transformative therapy in cardiovascular medicine. Currently, only the Edwards SAPIEN 3 Ultra, Medtronic EVOLUT FX, and Abbott Navitor valves have been approved by the FDA. Although most of the clinical experience with TAVR is linked to the Edwards and Medtronic valve systems, the potential transcatheter heart valves lineup extends beyond these leaders, with as many as five to ten new TAVR valves in the development phase. The future of TAVR appears bright, with indications growing, procedural volumes soaring, and an increasing number of clinical sites offering the procedure, although long-term durability remains a key concern. The leaflets of currently available valves are derived from porcine or bovine pericardial tissue. New valve platforms incorporating creative leaflet materials and other design innovations are being developed to increase long-term durability. Some new trials promise to offer crucial guidance for TAVR operators seeking to offer long-term solutions. The SMART (i.e., SMall Annuli Randomized to Evolut or SAPIEN) trial is the first randomized industry-sponsored (Medtronic) head-to-head comparison of the two most commonly used TAVR devices: SAPIEN 3 and Evolut in small anatomies. The trial was conducted at 83 international sites in North America, Europe, and the Middle East & Africa. The trial enrolled 716 participants with a small aortic annulus (aortic annulus area of 430 mm2 or less based on multi-detector computed tomography) and symptomatic severe native aortic stenosis. In April 2024, the American College of Cardiology announced that findings from the SMART trial demonstrated that patients with a small aortic annulus who underwent TAVR with Evolut valve had similar clinical outcomes and superior valve performance at one year compared with patients who underwent TAVR with SAPIEN 3 valve. Researchers said the results are encouraging in terms of the clinical outcomes of both valve types. Researchers will continue to track outcomes over the next five years. Thus, research and development activities focused on improving TAVI procedures are likely to bring in new trends in the balloon aortic valvuloplasty market.

Product Type -Based Insights

Based on product type, the balloon aortic valvuloplasty market is segmented into non compliant balloons and semi compliant balloons. The non compliant balloons segment held a larger balloon aortic valvuloplasty market share in 2023 and is expected to register a higher CAGR in the market during 2023-2031.

National Echo Database of Australia and the Institute of Health Economics are among the primary and secondary sources referred to while preparing the balloon aortic valvuloplasty market report.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Balloon Aortic Valvuloplasty Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Regional Pricing Analysis, By Product Type, 2023

5. Balloon Aortic Valvuloplasty Market - Key Market Dynamics

5.1 Balloon Aortic Valvuloplasty Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Aortic Valve Stenosis
- 5.2.2 Increasing Demand for Minimally Invasive Procedures
5.3 Market Restraints
- 5.3.1 High Cost of Procedures
5.4 Market Opportunities
- 5.4.1 Advancements in Aortic Valve Replacement Technologies
5.5 Future Trends
- 5.5.1 Improvements in TAVI Combined with Research and Development
5.6 Impact of Drivers and Restraints:

6. Balloon Aortic Valvuloplasty Market - Global Market Analysis

6.1 Balloon Aortic Valvuloplasty Market Revenue (US$ Thousand), 2021-2031
6.2 Market Positioning Analysis, 2023

7. Balloon Aortic Valvuloplasty Market Analysis - by Product Type

7.1 Overview
7.2 Global: Balloon Aortic Valvuloplasty Market - - Revenue and Forecast Analysis - by Product Type
7.3 Global: Balloon Aortic Valvuloplasty Market - - Volume and Forecast Analysis - by Product Type
7.4 Non Compliant Balloons
- 7.4.1 Overview
- 7.4.2 Non Compliant Balloons: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
7.5 Semi Compliant Balloons
- 7.5.1 Overview
- 7.5.2 Semi Compliant Balloons: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Balloon Aortic Valvuloplasty Market - Geographical Analysis

8.1 Overview
8.2 North America
- 8.2.1 North America Balloon Aortic Valvuloplasty Market Overview
- 8.2.2 North America: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
- 8.2.3 North America: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
  - 8.2.3.1 North America: Balloon Aortic Valvuloplasty Market - Revenue and Forecast Analysis - by Product Type
  - 8.2.3.2 North America: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis - by Product Type
- 8.2.4 North America: Balloon Aortic Valvuloplasty Market - Revenue and Forecast Analysis - by Country
  - 8.2.4.1 Canada: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.2.4.1.1 Canada: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.2.4.1.2 Canada: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.2.4.2 Mexico: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.2.4.2.1 Mexico: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.2.4.2.2 Mexico: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
8.3 Europe
- 8.3.1 Europe Balloon Aortic Valvuloplasty Market Overview
- 8.3.2 Europe: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
- 8.3.3 Europe: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
  - 8.3.3.1 Europe: Balloon Aortic Valvuloplasty Market - Revenue and Forecast Analysis - by Product Type
  - 8.3.3.2 Europe: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
- 8.3.4 Europe: Balloon Aortic Valvuloplasty Market - Revenue and Forecast Analysis - by Country
  - 8.3.4.1 Germany: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.3.4.1.1 Germany: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.3.4.1.2 Germany: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.3.4.2 United Kingdom: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.3.4.2.1 United Kingdom: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.3.4.2.2 United Kingdom: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.3.4.3 France: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.3.4.3.1 France: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.3.4.3.2 France: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.3.4.4 Italy: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.3.4.4.1 Italy: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.3.4.4.2 Italy: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.3.4.5 Spain: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.3.4.5.1 Spain: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.3.4.5.2 Spain: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.3.4.6 Rest of Europe: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.3.4.6.1 Rest of Europe: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.3.4.6.2 Rest of Europe: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
8.4 Asia Pacific
- 8.4.1 Asia Pacific Balloon Aortic Valvuloplasty Market Overview
- 8.4.2 Asia Pacific: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
- 8.4.3 Asia Pacific: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
  - 8.4.3.1 Asia Pacific: Balloon Aortic Valvuloplasty Market - Revenue and Forecast Analysis - by Product Type
  - 8.4.3.2 Asia Pacific: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
- 8.4.4 Asia Pacific: Balloon Aortic Valvuloplasty Market - Revenue and Forecast Analysis - by Country
  - 8.4.4.1 China: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.4.4.1.1 China: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.4.4.1.2 China: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.4.4.2 Japan: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.4.4.2.1 Japan: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.4.4.2.2 Japan: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.4.4.3 India: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.4.4.3.1 India: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.4.4.3.2 India: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.4.4.4 South Korea: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.4.4.4.1 South Korea: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.4.4.4.2 South Korea: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.4.4.5 Australia: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.4.4.5.1 Australia: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.4.4.5.2 Australia: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.4.4.6 Rest of APAC: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.4.4.6.1 Rest of APAC: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.4.4.6.2 Rest of APAC: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
8.5 Middle East and Africa
- 8.5.1 Middle East and Africa Balloon Aortic Valvuloplasty Market Overview
- 8.5.2 Middle East and Africa: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
- 8.5.3 Middle East and Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
  - 8.5.3.1 Middle East and Africa: Balloon Aortic Valvuloplasty Market - Revenue and Forecast Analysis - by Product Type
  - 8.5.3.2 Middle East and Africa: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
- 8.5.4 Middle East and Africa: Balloon Aortic Valvuloplasty Market - Revenue and Forecast Analysis - by Country
  - 8.5.4.1 Saudi Arabia: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.5.4.1.1 Saudi Arabia: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.5.4.1.2 Saudi Arabia: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.5.4.2 South Africa: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.5.4.2.1 South Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.5.4.2.2 South Africa: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.5.4.3 United Arab Emirates: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.5.4.3.1 United Arab Emirates: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.5.4.3.2 United Arab Emirates: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.5.4.4 Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.5.4.4.1 Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.5.4.4.2 Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
8.6 South and Central America
- 8.6.1 South and Central America Balloon Aortic Valvuloplasty Market Overview
- 8.6.2 South and Central America: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
- 8.6.3 South and Central America: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
  - 8.6.3.1 South and Central America: Balloon Aortic Valvuloplasty Market - Revenue and Forecast Analysis - by Product Type
  - 8.6.3.2 South and Central America: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
- 8.6.4 South and Central America: Balloon Aortic Valvuloplasty Market - Revenue and Forecast Analysis - by Country
  - 8.6.4.1 Brazil: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.6.4.1.1 Brazil: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.6.4.1.2 Brazil: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.6.4.2 Argentina: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.6.4.2.1 Argentina: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.6.4.2.2 Argentina: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.6.4.3 Rest of South and Central America: Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.6.4.3.1 Rest of South and Central America: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.6.4.3.2 Rest of South and Central America: Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type

9. Company Profiles

9.1 B Braun SE
- 9.1.1 Key Facts
- 9.1.2 Business Description
- 9.1.3 Products and Services
- 9.1.4 Financial Overview
- 9.1.5 SWOT Analysis
- 9.1.6 Key Developments
9.2 TT Medical, Inc.
- 9.2.1 Key Facts
- 9.2.2 Business Description
- 9.2.3 Products and Services
- 9.2.4 Financial Overview
- 9.2.5 SWOT Analysis
- 9.2.6 Key Developments
9.3 Balton
- 9.3.1 Key Facts
- 9.3.2 Business Description
- 9.3.3 Products and Services
- 9.3.4 Financial Overview
- 9.3.5 SWOT Analysis
- 9.3.6 Key Developments
9.4 Becton Dickinson and Co
- 9.4.1 Key Facts
- 9.4.2 Business Description
- 9.4.3 Products and Services
- 9.4.4 Financial Overview
- 9.4.5 SWOT Analysis
- 9.4.6 Key Developments
9.5 Edwards Lifesciences Corp
- 9.5.1 Key Facts
- 9.5.2 Business Description
- 9.5.3 Products and Services
- 9.5.4 Financial Overview
- 9.5.5 SWOT Analysis
- 9.5.6 Key Developments
9.6 Balt
- 9.6.1 Key Facts
- 9.6.2 Business Description
- 9.6.3 Products and Services
- 9.6.4 Financial Overview
- 9.6.5 SWOT Analysis
- 9.6.6 Key Developments
9.7 Venus MedTech HangZhou Inc
- 9.7.1 Key Facts
- 9.7.2 Business Description
- 9.7.3 Products and Services
- 9.7.4 Financial Overview
- 9.7.5 SWOT Analysis
- 9.7.6 Key Developments
9.8 NuMED
- 9.8.1 Key Facts
- 9.8.2 Business Description
- 9.8.3 Products and Services
- 9.8.4 Financial Overview
- 9.8.5 SWOT Analysis
- 9.8.6 Key Developments
9.9 Simeks
- 9.9.1 Key Facts
- 9.9.2 Business Description
- 9.9.3 Products and Services
- 9.9.4 Financial Overview
- 9.9.5 SWOT Analysis
- 9.9.6 Key Developments
9.10 OSYPKA
- 9.10.1 Key Facts
- 9.10.2 Business Description
- 9.10.3 Products and Services
- 9.10.4 Financial Overview
- 9.10.5 SWOT Analysis
- 9.10.6 Key Developments

10. Appendix

10.1 About The Insight Partners

풍선 대동맥 판막 성형술 시장 : 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 - 제품 유형별, 지역별 분석

Balloon Aortic Valvuloplasty Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type and Geography

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 풍선 대동맥 판막 성형술 시장 구도

제5장 풍선 대동맥 판막 성형술 시장 - 주요 시장 역학

제6장 풍선 대동맥 판막 성형술 시장 - 세계 시장 분석

제7장 풍선 대동맥 판막 성형술 시장 분석 - 제품 유형별

제8장 풍선 대동맥 판막 성형술 시장 : 지역별 분석